Renal Cancer
The association between age-related macular degeneration and renal cell carcinoma: a nested case-control study
January 12, 2017
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma
January 11, 2017
Biological Features of a Renal Cell Carcinoma Cell Line Derived from Spinal Metastasis
January 11, 2017
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
January 11, 2017
A Randomized Phase 2 Study of MK-2206 versus Everolimus in Refractory Renal Cell Carcinoma
January 11, 2017
Mixed Results for Sunitinib in Renal Cancer
January 9, 2017
Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma
January 9, 2017
Oncology Gold Standardâ„¢ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma.
January 9, 2017
How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma
January 9, 2017
Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma
January 9, 2017
Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
December 29, 2016
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
December 29, 2016
Laparoscopic Nephrectomy: Initial Case Report
December 29, 2016